Delivery Order SPE2DB20D3101-SPE2DB24FRJC1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,130.99, is a Delivery Order contract for the supply of CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRVV4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,420.48 firm fixed-price delivery order is for the supply of 4565911768 CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, with a final completion date of September 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,588.42 firm fixed-price delivery order is for the supply of 4567796165 CLOBAZAM 10 MG TABLET 100S, with a performance period through April 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,667.79 firm fixed price delivery order is for the supply of 4568821452 CLOBAZAM 10 MG TABLET 100S, with a period of performance ending on July 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization, holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award, valued at $5,655.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4564541392 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, to a location...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is a delivery order valued at $1,683.38 for the supply of 100 units of the medication CLOBAZAM 10 MG TABLET. The contract has an ultimate completion date of July 14, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.93 firm fixed-price delivery order is for the supply of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a performance period through June 25, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,377.25, is a delivery order for the supply of 4567825065 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $4,061.45 firm fixed price delivery order is for the supply of 4568822704 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,681.02 firm fixed-price delivery order is for the supply of 4566449615 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through November 18, 2024. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRJC1Delivery Order
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRJC1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.12 firm fixed-price delivery order contract covers the supply of CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a period of performance through May 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/1/24 |